Showing results (281-290 of 402) with videos related to
Sort By:
Pageof 41
BMJ Open|August 28, 2020
Novel approach to estimate tuberculosis transmission in primary care clinics in sub-Saharan Africa: protocol of a prospective studyKathrin Zürcher, Carl Morrow, Julien Riou, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitisAngela Loyse, Douglas Wilson, Graeme Meintjes, et al.AIDS (London, England)|April 20, 2004
Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjectsDaniel H Blanckenberg, Robin Wood, Andrzej Horban, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2012
Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studiesGilles Wandeler, Olivia Keiser, Lloyd Mulenga, et al.Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Within-country heterogeneity in patterns of social contact relevant for tuberculosis infection transmission, prevention, and careKate E LeGrand, Anita Edwards, Mbali Mohlamonyane, et al.The Pediatric Infectious Disease Journal|November 15, 2019
Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017Victoria Iyun, Karl-Gunter Technau, Brian Eley, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2010
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South AfricaRochelle P Walensky, Robin Wood, Mariam O Fofana, et al.AIDS (London, England)|December 4, 2002
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyureaPatrick G Hoggard, Stephen Kewn, Anlie Maherbe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2012
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitorsJessica H Brehm, Dianna L Koontz, Carole L Wallis, et al.Annals of Internal Medicine|April 2, 2019
Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling StudyCaitlin M Dugdale, Andrea L Ciaranello, Linda-Gail Bekker, et al.Pageof 41